NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Would someone please clarify for me how NWBO has any control of what approved therapeutics can, or can't be used with DCVax-L, or for that matter.

If DCVax-L is an approved product and Keytruda is an approved product how does a patent say you may, or may not, use both approved products together. Furthermore if the patent recommends using them together, is the maker of either or both products paying more to the patent holder for using them together. Likewise, if another approved product could be exchanged for Keytruda, what would prevent Doctors from using it if it was deemed to possibly be more effective for the patient.

I can understand having such a patent to suggest how to use DCVax-L effectively, but not how it will pay more that way, or how other products not covered by the patient shouldn't be used.

Gary